Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis

Yannick Allanore(Inserm), Mohamad Saad(Université Toulouse III - Paul Sabatier), Philippe Dieudé(Inserm), Jérôme Avouac(Inserm), Jörg H. W. Distler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Philippe Amouyel(Inserm), Marco Matucci‐Cerinic(University of Florence), Gabriella Riemekasten(Charité - Universitätsmedizin Berlin), Paolo Airo(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Inga Melchers(University Medical Center Freiburg), É. Hachulla(Université de Lille), Daniele Cusi(University of Milan), H.‐Erich Wichmann(Helmholtz Zentrum München), J. Wipff(Inserm), Jean‐Charles Lambert(Inserm), Nicolas Hunzelmann(University of Cologne), K.P. Tiev(Sorbonne Université), Paola Caramaschi(University of Verona), Élisabeth Diot(Inserm), Otylia Kowal‐Bielecka(Medical University of Białystok), Gabriele Valentini(University of Campania "Luigi Vanvitelli"), Luc Mouthon(Université Paris Cité), László Czirják(University of Pecs), Nemanja Damjanov(University of Belgrade), Erika Salvi(University of Milan), Costanza Conti, Martina Müller‐Nurasyid(Helmholtz Zentrum München), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), Valeria Riccieri(Sapienza University of Rome), Barbara Ruiz(Inserm), Jean-Luc Cracowski(Inserm), Luc Letenneur(Université de Bordeaux), Anne‐Marie Dupuy(Inserm), Oliver Meyer(Inserm), André Kahan(Inserm), Arnold Münnich(Inserm), Cathérine Boileau(Inserm), María Martínez(Université Toulouse III - Paul Sabatier)
PLoS Genetics
July 7, 2011
Cited by 229Open Access
Full Text

Abstract

Systemic sclerosis (SSc) is an orphan, complex, inflammatory disease affecting the immune system and connective tissue. SSc stands out as a severely incapacitating and life-threatening inflammatory rheumatic disease, with a largely unknown pathogenesis. We have designed a two-stage genome-wide association study of SSc using case-control samples from France, Italy, Germany, and Northern Europe. The initial genome-wide scan was conducted in a French post quality-control sample of 564 cases and 1,776 controls, using almost 500 K SNPs. Two SNPs from the MHC region, together with the 6 loci outside MHC having at least one SNP with a P<10(-5) were selected for follow-up analysis. These markers were genotyped in a post-QC replication sample of 1,682 SSc cases and 3,926 controls. The three top SNPs are in strong linkage disequilibrium and located on 6p21, in the HLA-DQB1 gene: rs9275224, P = 9.18×10(-8), OR = 0.69, 95% CI [0.60-0.79]; rs6457617, P = 1.14×10(-7) and rs9275245, P = 1.39×10(-7). Within the MHC region, the next most associated SNP (rs3130573, P = 1.86×10(-5), OR = 1.36 [1.18-1.56]) is located in the PSORS1C1 gene. Outside the MHC region, our GWAS analysis revealed 7 top SNPs (P<10(-5)) that spanned 6 independent genomic regions. Follow-up of the 17 top SNPs in an independent sample of 1,682 SSc and 3,926 controls showed associations at PSORS1C1 (overall P = 5.70×10(-10), OR:1.25), TNIP1 (P = 4.68×10(-9), OR:1.31), and RHOB loci (P = 3.17×10(-6), OR:1.21). Because of its biological relevance, and previous reports of genetic association at this locus with connective tissue disorders, we investigated TNIP1 expression. A markedly reduced expression of the TNIP1 gene and also its protein product were observed both in lesional skin tissue and in cultured dermal fibroblasts from SSc patients. Furthermore, TNIP1 showed in vitro inhibitory effects on inflammatory cytokine-induced collagen production. The genetic signal of association with TNIP1 variants, together with tissular and cellular investigations, suggests that this pathway has a critical role in regulating autoimmunity and SSc pathogenesis.


Related Papers

No related papers found

Powered by citation graph analysis